Literature DB >> 12108605

Application of rapid-cycle real-time polymerase chain reaction for the detection of microbial pathogens: the Mayo-Roche Rapid Anthrax Test.

James R Uhl1, Constance A Bell, Lynne M Sloan, Mark J Espy, Thomas F Smith, Jon E Rosenblatt, Franklin R Cockerill.   

Abstract

Rapid-cycle real-time polymerase chain reaction has immediate and important implications for diagnostic testing in the clinical microbiology laboratory. In our experience this novel testing method has outstanding performance characteristics. The sensitivities for detecting microorganisms frequently exceed standard culture-based assays, and the time required to complete the assays is considerably shorter than that required for culture-based assays. We describe the principle of real-time polymerase chain reaction and present clinical applications, including the detection of Bacillus anthracis, the causative agent of anthrax. This latter test is commercially available as the result of a collaborative venture between Mayo Clinic and Roche Applied Science, hence the designation The Mayo-Roche Rapid Anthrax Test.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12108605     DOI: 10.4065/77.7.673

Source DB:  PubMed          Journal:  Mayo Clin Proc        ISSN: 0025-6196            Impact factor:   7.616


  10 in total

1.  Genetics 101: polymerase chain reaction.

Authors:  Alison Sinclair
Journal:  CMAJ       Date:  2002-10-29       Impact factor: 8.262

Review 2.  Exposing a killer: pathologists angle for anthrax.

Authors:  Stephen W Chensue
Journal:  Am J Pathol       Date:  2003-11       Impact factor: 4.307

3.  Evaluation of a real-time PCR kit for detecting Escherichia coli O157 in bovine fecal samples.

Authors:  James L Bono; James E Keen; Laura C Miller; James M Fox; Carol G Chitko-McKown; Michael P Heaton; William W Laegreid
Journal:  Appl Environ Microbiol       Date:  2004-03       Impact factor: 4.792

Review 4.  Current and developing technologies for monitoring agents of bioterrorism and biowarfare.

Authors:  Daniel V Lim; Joyce M Simpson; Elizabeth A Kearns; Marianne F Kramer
Journal:  Clin Microbiol Rev       Date:  2005-10       Impact factor: 26.132

5.  PCR-based detection of Bacillus anthracis in formalin-fixed tissue from a patient receiving ciprofloxacin.

Authors:  Steven M Levine; Guillermo Perez-Perez; Asalia Olivares; Herman Yee; Bruce A Hanna; Martin J Blaser
Journal:  J Clin Microbiol       Date:  2002-11       Impact factor: 5.948

6.  Protocol for real-time PCR identification of anthrax spores from nasal swabs after broth enrichment.

Authors:  Marco R Oggioni; Francesca Meacci; Alessandra Carattoli; Alessandra Ciervo; Germano Orru; Antonio Cassone; Gianni Pozzi
Journal:  J Clin Microbiol       Date:  2002-11       Impact factor: 5.948

7.  Selective enrichment and detection of mycobacterial DNA in paucibacillary specimens.

Authors:  Blanca I Restrepo; Diana I Gomez; Gregory L Shipley; Joseph B McCormick; Susan P Fisher-Hoch
Journal:  J Microbiol Methods       Date:  2006-05-05       Impact factor: 2.363

8.  A novel semiquantitative fluorescence-based multiplex polymerase chain reaction assay for rapid simultaneous detection of bacterial and parasitic pathogens from blood.

Authors:  Angamuthu Selvapandiyan; Katie Stabler; Nasim A Ansari; Stephen Kerby; Jenny Riemenschneider; Poonam Salotra; Robert Duncan; Hira L Nakhasi
Journal:  J Mol Diagn       Date:  2005-05       Impact factor: 5.568

9.  Smallpox and pan-orthopox virus detection by real-time 3'-minor groove binder TaqMan assays on the roche LightCycler and the Cepheid smart Cycler platforms.

Authors:  David A Kulesh; Robert O Baker; Bonnie M Loveless; David Norwood; Susan H Zwiers; Eric Mucker; Chris Hartmann; Rafael Herrera; David Miller; Deanna Christensen; Leonard P Wasieloski; John Huggins; Peter B Jahrling
Journal:  J Clin Microbiol       Date:  2004-02       Impact factor: 5.948

10.  An overview of transforming changes at Mayo Clinic Proceedings during 2005.

Authors:  William L Lanier
Journal:  Mayo Clin Proc       Date:  2005-01       Impact factor: 7.616

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.